Roche Secures FDA Approval for First PTEN-Loss Companion Diagnostic in Prostate Cancer

Roche Diagnostics announced that the U.S. Food and Drug Administration has cleared its VENTANA PTEN (SP218) RxDx Assay, ...

Read story →

CMS Proposes Repeal of Breakthrough Device Pathway in FY 2027 Hospital Payment Rule

On April 14, 2026, the Centers for Medicare & Medicaid Services (CMS) set the stage for a seismic shift in hospital reim...

Read story →